AAC -- Table of Contents (November 1 1995, 39 [11])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Contents: November 1995, Volume 39, Issue 11

       Minireviews

       Articles

       Letters

Other Issues

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Minireviews:

Antimicrobial properties of tea (Camellia sinensis L.)
JM Hamilton-Miller
Antimicrob. Agents Chemother. November 1995 39: 2375-2377;
[PDF] [Reprints and Permissions]

Articles:

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
D Sanglard, K Kuchler, F Ischer, JL Pagani, M Monod, and J Bille
Antimicrob. Agents Chemother. November 1995 39: 2378-2386;
[Abstract] [PDF] [Reprints and Permissions]

MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates
M Maurin, S Gasquet, C Ducco, and D Raoult
Antimicrob. Agents Chemother. November 1995 39: 2387-2391;
[Abstract] [PDF] [Reprints and Permissions]

OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa
MM Hamzehpour, JC Pechere, P Plesiat, and T Kohler
Antimicrob. Agents Chemother. November 1995 39: 2392-2396;
[Abstract] [PDF] [Reprints and Permissions]

Antibiotics and prevention of microbial colonization of catheters
I Raad, R Darouiche, R Hachem, M Sacilowski, and GP Bodey
Antimicrob. Agents Chemother. November 1995 39: 2397-2400;
[Abstract] [PDF] [Reprints and Permissions]

Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients
KC Cundy, P Barditch-Crovo, RE Walker, AC Collier, D Ebeling, J Toole, and HS Jaffe
Antimicrob. Agents Chemother. November 1995 39: 2401-2405;
[Abstract] [PDF] [Reprints and Permissions]

In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus
D Strickman, T Sheer, K Salata, J Hershey, G Dasch, D Kelly, and R Kuschner
Antimicrob. Agents Chemother. November 1995 39: 2406-2410;
[Abstract] [PDF] [Reprints and Permissions]

Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa
K Weiss and JR Lapointe
Antimicrob. Agents Chemother. November 1995 39: 2411-2414;
[Abstract] [PDF] [Reprints and Permissions]

Staphylococcus aureus penicillin-binding protein 4 and intrinsic beta- lactam resistance
UU Henze and B Berger-Bachi
Antimicrob. Agents Chemother. November 1995 39: 2415-2422;
[Abstract] [PDF] [Reprints and Permissions]

Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination
P Brouqui, MC Rousseau, A Stein, M Drancourt, and D Raoult
Antimicrob. Agents Chemother. November 1995 39: 2423-2425;
[Abstract] [PDF] [Reprints and Permissions]

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1
JO Ojwang, RW Buckheit, Y Pommier, A Mazumder, K De Vreese, JA Este, D Reymen, LA Pallansch, C Lackman-Smith, and TL Wallace
Antimicrob. Agents Chemother. November 1995 39: 2426-2435;
[Abstract] [PDF] [Reprints and Permissions]

Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii
MS Bartlett, M Shaw, P Navaran, JW Smith, and SF Queener
Antimicrob. Agents Chemother. November 1995 39: 2436-2441;
[Abstract] [PDF] [Reprints and Permissions]

Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin
JS Knapp, JA Hale, SW Neal, K Wintersheid, RJ Rice, and WL Whittington
Antimicrob. Agents Chemother. November 1995 39: 2442-2445;
[Abstract] [PDF] [Reprints and Permissions]

Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium
S Handwerger and J Skoble
Antimicrob. Agents Chemother. November 1995 39: 2446-2453;
[Abstract] [PDF] [Reprints and Permissions]

Inhibition of influenza virus transcription by 2'-deoxy-2'- fluoroguanosine
M Tisdale, M Ellis, K Klumpp, S Court, and M Ford
Antimicrob. Agents Chemother. November 1995 39: 2454-2458;
[Abstract] [PDF] [Reprints and Permissions]

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans
MA Ghannoum, Y Fu, AS Ibrahim, LA Mortara, MC Shafiq, JE Edwards, Jr, and RS Criddle
Antimicrob. Agents Chemother. November 1995 39: 2459-2465;
[Abstract] [PDF] [Reprints and Permissions]

Intracellular accumulation of norfloxacin in Mycobacterium smegmatis
S Corti, J Chevalier, and A Cremieux
Antimicrob. Agents Chemother. November 1995 39: 2466-2471;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
DA Rouse, Z Li, GH Bai, and SL Morris
Antimicrob. Agents Chemother. November 1995 39: 2472-2477;
[Abstract] [PDF] [Reprints and Permissions]

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli
P Stapleton, PJ Wu, A King, K Shannon, G French, and I Phillips
Antimicrob. Agents Chemother. November 1995 39: 2478-2483;
[Abstract] [PDF] [Reprints and Permissions]

Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
K Mikusova, RA Slayden, GS Besra, and PJ Brennan
Antimicrob. Agents Chemother. November 1995 39: 2484-2489;
[Abstract] [PDF] [Reprints and Permissions]

Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity [published erratum appears in Antimicrob Agents Chemother 1996 May;40(5):1330]
F Nassar, E Brummer, and DA Stevens
Antimicrob. Agents Chemother. November 1995 39: 2490-2493;
[Abstract] [PDF] [Reprints and Permissions]

DNA sequence differences of ampD mutants of Citrobacter freundii
P Stapleton, K Shannon, and I Phillips
Antimicrob. Agents Chemother. November 1995 39: 2494-2498;
[Abstract] [PDF] [Reprints and Permissions]

Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings
M Osterblad, J Leistevuo, T Leistevuo, H Jarvinen, L Pyy, J Tenovuo, and P Huovinen
Antimicrob. Agents Chemother. November 1995 39: 2499-2502;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa
ME Klepser, KB Patel, DP Nicolau, R Quintiliani, and CH Nightingale
Antimicrob. Agents Chemother. November 1995 39: 2503-2510;
[Abstract] [PDF] [Reprints and Permissions]

Methionine recycling pathways and antimalarial drug design
JR Sufrin, SR Meshnick, AJ Spiess, J Garofalo-Hannan, XQ Pan, and CJ Bacchi
Antimicrob. Agents Chemother. November 1995 39: 2511-2515;
[Abstract] [PDF] [Reprints and Permissions]

Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. The Vigil'Roc Study Group
FW Goldstein, Y Pean, and J Gertner
Antimicrob. Agents Chemother. November 1995 39: 2516-2519;
[Abstract] [PDF] [Reprints and Permissions]

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates
A Wanger, K Mills, PW Nelson, and JH Rex
Antimicrob. Agents Chemother. November 1995 39: 2520-2522;
[Abstract] [PDF] [Reprints and Permissions]

Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro
JA Bilello, PA Bilello, JJ Kort, MN Dudley, J Leonard, and GL Drusano
Antimicrob. Agents Chemother. November 1995 39: 2523-2527;
[Abstract] [PDF] [Reprints and Permissions]

Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis
D Henry, GE Ruoff, J Rhudy, A Puopolo, M Drehobl, J Schoenberger, G Giguere, and JJ Collins
Antimicrob. Agents Chemother. November 1995 39: 2528-2534;
[Abstract] [PDF] [Reprints and Permissions]

Prevention of experimental endotoxin shock by a monocyte activator
B Passlick, MO Labeta, JR Izbicki, P Ostertag, T Loffler, M Siebeck, U Pichlmeier, L Schweiberer, and HW Ziegler-Heitbrock
Antimicrob. Agents Chemother. November 1995 39: 2535-2540;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms
M Lauterwein, M Oethinger, K Belsner, T Peters, and R Marre
Antimicrob. Agents Chemother. November 1995 39: 2541-2543;
[Abstract] [PDF] [Reprints and Permissions]

In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin
M Tsuji, Y Ishii, A Ohno, S Miyazaki, and K Yamaguchi
Antimicrob. Agents Chemother. November 1995 39: 2544-2551;
[Abstract] [PDF] [Reprints and Permissions]

Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease
DG Wolf, DJ Lee, and SA Spector
Antimicrob. Agents Chemother. November 1995 39: 2552-2554;
[Abstract] [PDF] [Reprints and Permissions]

Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells
T Shirasaka, S Chokekijchai, A Yamada, G Gosselin, JL Imbach, and H Mitsuya
Antimicrob. Agents Chemother. November 1995 39: 2555-2559;
[Abstract] [PDF] [Reprints and Permissions]

Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile
F Fitoussi, C Doit, A Sandin, A Pechinot, A Kazmierczack, P Geslin, and E Bingen
Antimicrob. Agents Chemother. November 1995 39: 2560-2563;
[Abstract] [PDF] [Reprints and Permissions]

In vitro and in vivo antibiotic susceptibilities of ELB rickettsiae [published erratum appears in Antimicrob Agents Chemother 1996 Dec;40(12):2912]
S Radulovic, JA Higgins, DC Jaworski, and AF Azad
Antimicrob. Agents Chemother. November 1995 39: 2564-2566;
[Abstract] [PDF] [Reprints and Permissions]

The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon
N Gotoh, H Tsujimoto, K Poole, J Yamagishi, and T Nishino
Antimicrob. Agents Chemother. November 1995 39: 2567-2569;
[Abstract] [PDF] [Reprints and Permissions]

Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine
JO Ojwang, BK Bhattacharya, HB Marshall, BE Korba, GR Revankar, and RF Rando
Antimicrob. Agents Chemother. November 1995 39: 2570-2573;
[Abstract] [PDF] [Reprints and Permissions]

Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice
JP Wong, EG Saravolac, D Sabuda, HB Levy, and M Kende
Antimicrob. Agents Chemother. November 1995 39: 2574-2576;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis
JM Blondeau and Y Yaschuk
Antimicrob. Agents Chemother. November 1995 39: 2577-2579;
[Abstract] [PDF] [Reprints and Permissions]

First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains
J Lemozy, D Sirot, C Chanal, C Huc, R Labia, H Dabernat, and J Sirot
Antimicrob. Agents Chemother. November 1995 39: 2580-2582;
[Abstract] [PDF] [Reprints and Permissions]

GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets
DM Ryan, J Ticehurst, and MH Dempsey
Antimicrob. Agents Chemother. November 1995 39: 2583-2584;
[Abstract] [PDF] [Reprints and Permissions]

Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria [published erratum appears in Antimicrob Agents Chemother 1996 May;40(5):1330]
TI Nicas, DL Mullen, JE Flokowitsch, DA Preston, NJ Snyder, RE Stratford, and RD Cooper
Antimicrob. Agents Chemother. November 1995 39: 2585-2587;
[Abstract] [PDF] [Reprints and Permissions]

Successful treatment of cryptococcal meningitis with amphotericin B colloidal dispersion: report of four cases
G Valero and JR Graybill
Antimicrob. Agents Chemother. November 1995 39: 2588-2590;
[Abstract] [PDF] [Reprints and Permissions]

Letters:

Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio
CJ Thomson, RS Miles, and SG Amyes
Antimicrob. Agents Chemother. November 1995 39: 2591-2592;
[PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.